Unit 1.1: DNA, RNA, and Protein Synthesis – An Overview

This session provides an introduction to the central dogma of molecular biology, covering the structure and function of DNA, RNA, and proteins. It highlights the processes of transcription and translation, emphasizing how genetic information is converted into functional proteins that drive cellular processes.

Unit 1.2: Gene Structure, Function, and Regulation

Dive deeper into gene architecture, exploring the roles of exons, introns, promoters, and enhancers. This session covers the mechanisms of gene expression regulation, including transcription factors, epigenetic modifications, and post-transcriptional control, crucial for understanding how genes are turned on and off in response to various stimuli.

Unit 2.1: Polymerase Chain Reaction (PCR) and Its Applications

PCR is a fundamental tool in molecular biology and drug development. This session covers the principles of PCR, its various types (e.g., qPCR, RT-PCR), and its applications in detecting genetic mutations, pathogen identification, and personalized medicine.

Unit 2.2: CRISPR-Cas9 Gene Editing: Principles and Uses in Medicine

CRISPR-Cas9 technology has revolutionized genetic engineering. This session introduces the basic concepts of CRISPR, how it works, and its applications in gene therapy, drug development, and correcting genetic disorders.

Unit  3.1: Genetic Polymorphisms and Their Impact on Drug Response

This session explores the role of genetic polymorphisms in drug metabolism and efficacy. Understanding these variations can help optimize drug dosing, reduce adverse effects, and improve therapeutic outcomes.

Unit 3.2: Implementing Pharmacogenomic Data in Clinical Practice

Learn how to integrate pharmacogenomic data into everyday clinical practice. This session covers case studies, clinical guidelines, and the use of decision support tools to tailor drug therapy based on a patient’s genetic makeup.

Unit 4.1: Molecular Mechanisms in Cancer Development and Progression

Cancer is a disease of altered molecular pathways. This session examines the genetic and epigenetic changes that lead to oncogenesis, including mutations in tumor suppressor genes and oncogenes, and how these insights guide targeted cancer therapies.

Unit 4.2: Understanding the Molecular Biology of Infectious Diseases

Explore the molecular interactions between pathogens and host cells, focusing on how these interactions lead to disease. This session covers viral replication, bacterial gene regulation, and emerging molecular targets for combating infectious diseases.

Unit 5.1: The Science Behind Monoclonal Antibodies and Biologics

Biologics represent a rapidly growing class of therapeutics. This session covers the development, structure, and function of monoclonal antibodies and other biologics, with a focus on their mechanisms of action and therapeutic applications.

Unit 5.2: Challenges and Opportunities in Developing Biosimilars

As patents for biologics expire, biosimilars are becoming more important. This session discusses the regulatory, clinical, and manufacturing challenges of developing biosimilars, as well as their potential to reduce healthcare costs while maintaining therapeutic efficacy.